A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LTRAs / leukotriene receptor antagonists

[Related PubMed/MEDLINE]
Total Number of Papers: 137
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LTRAs  (>> Co-occurring Abbreviation)
Long Form:   leukotriene receptor antagonists
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
1  2023 Montelukast Increased IL-25, IL-33, and TSLP via Epigenetic Regulation in Airway Epithelial Cells. IL, MAPK, NF-kappaB, TSLP
2  2022 A Comparison of the Effectiveness of Asthma Medications on Asthma Exacerbations in Real World National Cohort. HR, ICSs, LABAs, LAMAs
3  2022 Cysteinyl Leukotriene Receptor Antagonists Associated With a Decreased Incidence of Cancer: A Retrospective Cohort Study. aHR, CI, HRs, RCTs
4  2022 Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19. NERD, NSAIDs
5  2022 Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma. CRS, CSS, CVA, FeNO, VAS
6  2022 Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study. TS
7  2022 Leukotriene Receptor Antagonists and Risk of Neuropsychiatric Entities: A Meta-Analysis of Observational Studies. AR, CI, NP, OR
8  2022 Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series. AR, IRRs, NPEs, Obs2
9  2022 Prescription Patterns of Asthma Preventers Among Children and Adolescents Between Australia and South Korea. ICSs
10  2022 The safety of pranlukast and montelukast during the first trimester of pregnancy: A prospective, two-centered cohort study in Japan. ---
11  2021 Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review. ADRs, CYP, RCT
12  2021 Effectiveness of omalizumab in children and adolescents with uncontrolled allergic asthma: a case series from Poland. ACQ, GETE, ICS, MiniAQLQ, OCS
13  2021 Efficacy and safety of add-on tiotropium in the management of uncontrolled asthma: a patient case series. ICS
14  2021 Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia. AD, MCI
15  2021 Leukotriene Receptor Antagonist Use and Dementia Risk in Patients With Asthma: A Retrospective Cohort Study. ---
16  2021 Leukotrienes Are Dispensable for Vaginal Neutrophil Recruitment as Part of the Immunopathological Response During Experimental Vulvovaginal Candidiasis. LTs, PMNs, RVVC, VVC
17  2021 Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence. AR, CI, MD, OR, QoL, RCTs, RQLQ, SAHs
18  2021 Management of Pediatric Chronic Spontaneous Urticaria: A Review of Current Evidence and Guidelines. CSU, CU, fgAHs, RCTs, sgAHs
19  2021 Prescription rate and treatment patterns for allergic rhinitis from 2010 to 2018 in South Korea: a retrospective study. AR
20  2021 The Addition of Montelukast for the Treatment of Chronic Idiopathic Urticaria. CU
21  2020 A case-control study: Evaluating the role of leukotriene receptor antagonists in preventing the cardiovascular and cerebrovascular disease. IS, MI
22  2020 A comparison of tiotropium, long-acting beta2-agonists and leukotriene receptor antagonists on lung function and exacerbations in paediatric patients with asthma. AEs, ICS, LABAs, LAMAs, RCTs
23  2020 Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management. ICS, LABAs, LAMA
24  2020 The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial. ACF, CRC, UMIN
25  2019 A Comparison of Leukotriene Receptor Antagonists to Low-Dose Inhaled Corticosteroids in the Elderly with Mild Asthma. ICSs
26  2019 Anti-Neutrophil Cytoplasmic Antibodies Positivity and Anti-Leukotrienes in Eosinophilic Granulomatosis with Polyangiitis: A Retrospective Monocentric Study on 134 Italian Patients. ANCA, EGPA
27  2019 Influence of weight status in the response to Step-2 maintenance therapies in children with asthma. BMI, ICS, LRT, RERI
28  2019 Management of paediatric obstructive sleep apnoea: A systematic review and network meta-analysis. AHI, ODI, OSA, RME
29  2018 Association between dry eye disease and asthma: a nationwide population-based study. CI, DED, OR
30  2018 Comparison of clinical characteristics and management of asthma by types of health care in South Korea. HIRA, PFT
31  2018 Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest. Bax, Bcl-2
32  2018 Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis. CysLTR1, DDAH1, DEPs, KO, NO, PKCdelta, WB, WT
33  2018 Leukotriene receptor antagonists for eczema. CI, EASI, SCORAD
34  2018 Oral Antihistamines Alone vs in Combination with Leukotriene Receptor Antagonists for Allergic Rhinitis: A Meta-analysis. AR, CI, RCTs, WMD
35  2017 Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. AMED, CENTRAL, CI, CINAHL, ICS, MD, NNTB, PEFR, RCTs, RR
36  2017 Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma. CysLT1
37  2017 Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. ---
38  2017 The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field. 5-LO
39  2016 Antileukotriene Agents Versus Long-Acting Beta-Agonists in Older Adults with Persistent Asthma: A Comparison of Add-On Therapies. CV, FFS, ICSs, LABAs, OR
40  2016 Cysteinyl Leukotriene Receptor Antagonists Decrease Cancer Risk in Asthma Patients. ---
41  2016 Leukotriene Receptor Antagonists and Antiallergy Drugs. AR, EIA, ICS, LABA, TXA2
42  2016 Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients. COPD, EA, ICS
43  2015 Addition to inhaled corticosteroids of leukotriene receptor antagonists versus theophylline for symptomatic asthma: a meta-analysis. CI, ICSs, MD, PEF, RCTs
44  2015 Effectiveness of drug treatment strategies to prevent asthma exacerbations and increase symptom-free days in asthmatic children: a network meta-analysis. ICS, LABA
45  2015 Genome-Wide Association Study Identifies Novel Pharmacogenomic Loci For Therapeutic Response to Montelukast in Asthma. ALA-ACRC, GWAS, SNPs
46  2015 Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children. EVW, OR
47  2015 Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents: a systematic review and meta-analysis. RR
48  2015 Side Effects of Leukotriene Receptor Antagonists in Asthmatic Children. ---
49  2015 [A comparative study on efficiency of different therapeutics methods used for obstructive sleep apnea hypopnea syndrome in children]. AHI, MAT, MM, ODI, OSA-18, OSAHS, PSG, SAT, SM
50  2014 New efficacy of LTRAs (montelukast sodium): it possibly prevents food-induced abdominal symptoms during oral immunotherapy. CM, HE, OIT
51  2014 Symptomatic treatment of the cough in whooping cough. CI, MD, RCTs
52  2014 The changing face of severe childhood asthma: a comparison of two cohorts of children evaluated at National Jewish Health over the past 20 years. GCs, LABAs
53  2014 The role of leukotriene receptor antagonists in exercise induced bronchoconstriction in children. EIB
54  2014 [Discussion on the treatment methods of pediatric obstructive sleep apnea hypopnea syndrome]. OSAHS, PSG
55  2013 A randomized, double-blind, placebo-controlled trial of oral montelukast in acute asthma exacerbation. ---
56  2013 Comparative outcomes of leukotriene receptor antagonists and long-acting beta-agonists as add-on therapy in asthmatic patients: a population-based study. ICSs, ITT, LABAs
57  2013 Cough, asthma, and cysteinyl-leukotrienes. CVA
58  2013 Leukotriene receptor antagonists for small-airway abnormalities in asthmatics: a systematic review and meta-analysis. CI, ICSs, MD, SMD
59  2013 Leukotriene receptor antagonists in allergic eye disease: a systematic review and meta-analysis. AC
60  2013 Leukotriene receptor antagonists pranlukast and montelukast for treating asthma. CysLTs, ICS
61  2012 Association between episodes of upper respiratory infection and exacerbations in adult patients with asthma. CI, ICSs, OR, OR, URI
62  2012 Characterization of long-acting beta₂-adrenergic agonists utilization in asthma patients. FDA, FDC, ICS, LABAs, MCR, SI
63  2012 Inhibition of common cold-induced aggravation of childhood asthma by leukotriene receptor antagonists. ACT, C-ACT
64  2012 Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma. ICSs, MLK
65  2012 Symptomatic treatment of the cough in whooping cough. CI, MD, RCTs
66  2012 Update on leukotriene receptor antagonists in preschool children wheezing disorders. ICS, LTs
67  2011 Clinical, physiological and anti-inflammatory effect of montelukast in patients with cough variant asthma. CVA, PG, VAS
68  2011 Comparison of leukotriene receptor antagonists and anti-histamines as an add-on therapy in patients with asthma complicated by allergic rhinitis. ---
69  2011 Delay of onset of symptoms of Japanese cedar pollinosis by treatment with a leukotriene receptor antagonist. ---
70  2011 That ICS should be first line therapy for asthma--con. ICS
71  2010 Add-on montelukast to inhaled corticosteroids protects against excessive airway narrowing. ICS
72  2010 Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. ---
73  2010 Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial. ICS
74  2010 Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial. ACQ, beta2 agonists, ICS, MiniAQLQ
75  2010 Effects of leukotriene receptor antagonists on peripheral eosinophil counts and serum IgE levels in children with food allergy. ECP, IL
76  2010 Protection of leukotriene receptor antagonist against aspirin-induced bronchospasm in asthmatics. AIA
77  2010 Symptomatic treatment of the cough in whooping cough. CENTRAL, CI, DARE, RCTs
78  2010 [The influence of leukotriene receptor antagonists treatment on Churg-Strauss syndrome]. CSS
79  2009 Churg Strauss Syndrome after polypectomy in asthmatic and allergic patients. CSS
80  2009 Development of Churg-Strauss syndrome with severe multiple mononeuropathy after leukotriene receptor antagonist treatment in one of the monozygotic twins with asthma: case report. CSS
81  2009 Exercise-induced bronchoconstriction in asthmatic children: a comparative systematic review of the available treatment options. EIB, EL, GR, ICSs, RCTs
82  2009 Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis--a randomized placebo-controlled study. FEX
83  2009 [Efficacy of leukotriene receptor antagonists in asthma treatment and analysis of background factors evaluated by a questionnaire survey among physicians]. ---
84  2008 Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? FSH, IS, LH, PEFR, PFT, PMA
85  2008 The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction? CSS
86  2007 Antileukotriene drugs: clinical application, effectiveness and safety. 5-LO, CysLTs
87  2007 Antileukotrienes as adjunctive therapy in acute asthma. ---
88  2007 Churg Strauss syndrome after introducing oral steroid to inhaler: a report of three cases. ---
89  2007 Clinical evaluation of leukotriene receptor antagonists in preventing common cold-like symptoms in bronchial asthma patients. ICS
90  2007 Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. FeNO
91  2007 Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA). CysLTR1, EIA, EIB, FEV1, LTC4S
92  2007 Safety of leukotriene receptor antagonists in pregnancy. ---
93  2007 Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers. ALOX5, CysLTR1, CysLTs, ICS, LT, LTA4H, LTC4S, MRP1
94  2006 Asthma control in Switzerland: a general practitioner based survey. ACQ, GINA, ICS
95  2006 Asthma mortality in portugal : impact of treatment with inhaled corticosteroids and leukotriene receptor antagonists. DDDs
96  2006 Cysteinyl-leukotriene receptor antagonists: present situation and future opportunities. CysLTRs
97  2006 Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. LT
98  2006 Effects of anti-inflammatory therapies on recurrent and low-grade respiratory syncytial virus infections in a murine model of asthma. IFN-gamma, IL-5, RLRIs, RSV
99  2006 Effects of leukotriene receptor antagonists on monocyte chemotaxis, p38 and cytoplasmic calcium. CBMCs, MCP-1, PBMCs
100  2006 Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. AR, ECP, NAR, PAR, PRQLQ, TSS